"Also if you do a slight bit of research"
Research what exactly? I know that the one completed study from that other company was for
'oral cancer' which represents 3% or less of all cancers and the other trials are all in progress
and just like ours, they can fail.
IBX has intimated that they will (in the future) together with their collaborators and partners will
be targeting other forms of cancers including other more common breast cancers -
Global Cancer Technology
A Joint Development Agreement aims to develop GCT’s novel nanoscintillator technology for
the treatment of breast cancer. Preliminary work commenced under this agreement in 2021.
Patrys Limited
A collaborative research program with Patrys Limited aims to combine technologies to
improve brain tumor imaging and diagnosis. Research engagement with The University of
Sydney
Also intimated by IBX was a future Prostate cancer trial.
The other company is funded by venture capital and the South Aust Govt, therefore, not open to
private investors and as such it's not a listed ASX company.
As I've stated many times before on these threads; it was people like Mike Harsh (Absolute Guro
in the imaging and product development space) that ultimately led me to IBX.
Anyway, a bit too presumptive for anyone to start getting carried away, but I like what I see here.
Also, there's no room for cross-promotion here, therefore, posters should refrain from this behaviour.
Finally, from the other Co's own website comes the following caveat -
Caution: Ferronova products are undergoing clinical trials and are not approved for commercial use.
Cheers, all.
- Forums
- ASX - By Stock
- IBX
- Ann: Change of Director's Interest Notice
Ann: Change of Director's Interest Notice, page-56
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IBX (ASX) to my watchlist
|
|||||
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.364M |
Open | High | Low | Value | Volume |
3.9¢ | 3.9¢ | 3.9¢ | $96 | 2.47K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 7371 | 3.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.0¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7371 | 0.039 |
1 | 15000 | 0.038 |
1 | 10000 | 0.037 |
1 | 15000 | 0.036 |
3 | 294073 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.040 | 50000 | 1 |
0.044 | 1422 | 1 |
0.045 | 2730 | 1 |
0.056 | 6320 | 1 |
0.058 | 14821 | 1 |
Last trade - 16.10pm 20/08/2024 (20 minute delay) ? |
Featured News
IBX (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
MD - Shanthar Pathmanathan, Geologist - David Trabert
MD - Shanthar Pathmanathan
Geologist - David Trabert
SPONSORED BY The Market Online